SEC CIK 1361379
Fennebresque Kim S
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| RBBNview stock → | 84,076 | 2020-02-21 |
| ALLYview stock → | 68,002 | 2026-05-15 |
| BXCview stock → | 0 | 2026-08-06 |
Position History — BXC
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BXC
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-08-06 | Open-market sale | 34,138 | $84.15 | 0 |
| 2026-05-19 | Option exercise (derivative) | 3,218 | $0.00 | 0 |
| 2026-05-19 | Option exercise | 3,218 | — | 12,982 |
| 2026-05-18 | Grant / award (derivative) | 4,266 | $0.00 | 4,266 |
| 2025-05-19 | Grant / award (derivative) | 3,218 | $0.00 | 3,218 |
| 2025-05-17 | Option exercise (derivative) | 2,234 | $0.00 | 0 |
| 2025-05-17 | Option exercise | 2,234 | — | 9,764 |
| 2024-05-18 | Option exercise (derivative) | 2,601 | $0.00 | 0 |
| 2024-05-18 | Option exercise | 2,601 | — | 7,530 |
| 2024-05-17 | Grant / award (derivative) | 2,234 | $0.00 | 2,234 |
| 2023-05-19 | Option exercise (derivative) | 1,926 | $0.00 | 0 |
| 2023-05-19 | Option exercise | 1,926 | — | 4,929 |
| 2023-05-18 | Grant / award (derivative) | 2,601 | $0.00 | 2,601 |
| 2022-05-20 | Option exercise (derivative) | 3,003 | $0.00 | 0 |
| 2022-05-20 | Option exercise | 3,003 | — | 3,003 |
| 2022-05-19 | Grant / award (derivative) | 1,926 | $0.00 | 1,926 |
| 2021-09-15 | Open-market sale | 4,264 | $50.32 | 0 |
| 2021-09-14 | Open-market sale | 3,055 | $53.02 | 4,264 |
| 2021-09-13 | Open-market sale | 3,500 | $53.66 | 7,319 |
| 2021-09-10 | Open-market sale | 9,693 | $55.93 | 10,819 |
| 2021-09-09 | Disposition to issuer | 3,360 | $55.42 | 20,513 |
| 2021-09-07 | Disposition to issuer | 5,977 | $57.17 | 23,873 |
| 2021-05-20 | Grant / award (derivative) | 3,003 | $0.00 | 3,003 |
| 2020-08-07 | Gift | 29,850 | $0.00 | 29,850 |
| 2020-08-07 | Gift | 29,850 | $0.00 | 0 |
| 2020-08-07 | Open-market sale | 25,000 | $18.15 | 29,850 |
| 2020-08-05 | Open-market buy | 25,000 | $19.58 | 54,850 |
| 2020-05-21 | Grant / award (derivative) | 21,334 | $0.00 | 21,334 |
| 2019-05-17 | Grant / award (derivative) | 9,485 | $0.00 | 9,485 |
| 2018-03-15 | Open-market buy | 2,482 | $33.96 | 10,000 |
| 2018-03-13 | Open-market buy | 7,518 | $33.25 | 7,518 |
| 2018-03-13 | Open-market buy | 15,000 | $30.60 | 19,850 |
| 2018-03-13 | Open-market buy | 10,000 | $30.60 | 29,850 |
| 2018-01-11 | Grant / award (derivative) | 15,108 | $0.00 | 15,108 |
| 2017-01-11 | Grant / award (derivative) | 0 | $0.00 | 272,735 |
| 2016-05-20 | Grant / award (derivative) | 102,941 | $0.00 | 250,482 |
| 2016-03-31 | Grant / award (derivative) | 147,541 | $0.00 | 147,541 |
| 2016-01-13 | Option exercise (derivative) | 90,909 | $0.00 | 0 |
| 2016-01-13 | Option exercise | 90,909 | $0.00 | 139,401 |
| 2015-01-13 | Grant / award (derivative) | 90,909 | $0.00 | 90,909 |
| 2014-01-14 | Grant / award | 28,249 | $0.00 | 48,492 |
| 2013-05-21 | Grant / award | 20,243 | $0.00 | 20,243 |
| 2013-05-16 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.